Crohn's Disease and Colitis Trial, Recruiting NCT05230173 Sponsor: University of California, San Diego Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05230173
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are male, or female and neither pregnant nor breastfeeding
  • People who have been diagnosed with Crohn's disease (CD) or ulcerative colitis (UC) for at least 6 months, confirmed by their treating doctor
  • People currently being treated with an approved medication for inflammatory bowel disease (IBD), such as biologics (for example, TNF blockers, ustekinumab, or vedolizumab) or certain newer tablet-based treatments (for example, JAK inhibitors or ozanimod)
  • People whose IBD medication dose has been stable for 3 or more months before their qualifying scan or camera test, with no increases in medication or new medications added between that test and the start of the trial
  • People whose IBD symptoms are well controlled (in remission) without the use of steroids, based on a short patient-reported symptom score, as judged by their treating doctor
  • People whose most recent bowel camera test (such as a colonoscopy) or imaging scan (such as an MRI or CT) — done within the past 6 months — shows moderate to severe inflammation inside the bowel, based on specific scoring systems (confirm with trial site)
  • People for whom at least one other approved IBD medication (different from their current one) would be considered appropriate to use by their doctor under approved prescribing guidelines
  • People who are able to take part fully in all parts of the trial
  • People who have given written informed consent to participate

Who may not be able to join:

  • People who have a stoma (ostomy bag) or an internal pouch (ileoanal pouch) as a result of bowel surgery
  • People who have another serious health condition, unrelated to UC or CD, that the trial doctor believes could affect their ability to take part fully
  • People with a history of alcohol or drug misuse, or any other health condition the trial doctor believes could affect their ability to follow the trial procedures
  • People who have previously been enrolled in this same trial
  • People whose bowel inflammation is only mild on their camera test, where their treating doctor would not normally consider changing their current IBD medication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Siddharth Singh, MD, UC San Diego Health

Phone: 858-246-2352

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 October 2022
Est. completion
1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time to Treatment Failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov